🔗 Permalink

Assignee profile:

DIAMEDICA INC.

City:

Winnipeg

Country:

Canada

Published Applications:

Last publication date:

2017-05-04

Patent Grants:

Last grant date:

2017-12-12

Top Inventors for applications by DIAMEDICA INC.

These are the the leading inventors for applications assigned to DIAMEDICA INC.:

Matthew Charles 3 St. Louis Park, MN United States
Paula Macedo 2 Caxias, Portugal
Tadeusz Kolodka 2 Plymouth, MN United States
W Wayne Lautt 2 Winnipeg, Canada

Mark WILLIAMS 2 Winnipeg, Canada
Matthew L. Charles 2 St. Louis Park, MN United States
Wilfred Wayne Lautt 2 Winnipeg, Canada
Mark Williams 2 Plymouth, MN United States

Paula Macedo 1 Caxiaa, Canada
Kevin Richardson 1 Winnipeg, Canada
Matthew L. Charles 1 Winnipeg, Canada
Mark S Willimas 1 Plymouth, MN United States

Mark S. Williams 1 Plymouth, MN United States
Mark S. Williams 1 Winnipeg, Canada

Recent patent applications by DIAMEDICA INC.

DIAMEDICA INC. based in Winnipeg, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-05-04 ✅ Patent 9,839,678 granted on 2017-12-12

US20170119862A1

Human necessities

Human tissue kallikrein 1 glycosylation isoforms

#2 | 2016-01-07 ✅ Patent 9,616,015 granted on 2017-04-11

US20160000704A1

Human necessities

Formulations of human tissue kallikrein-1 for parenteral delivery and related methods

#3 | 2015-07-16 ✅ Patent 9,364,521 granted on 2016-06-14

US20150196624A1

Human necessities

Human tissue kallikrein 1 glycosylation isoforms

#4 | 2014-05-15

US20140134152A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING DIABETES

#5 | 2014-01-16

US20140017242A1

Chemistry; metallurgy

ANTI-BRADYKININ B2 RECEPTOR (BKB2R) MONOCLONAL ANTIBODY

#6 | 2012-11-01

US20120276019A1

Human necessities

TISSUE KALLIKREIN FOR THE TREATMENT OF PARKINSON'S DISEASE

#7 | 2012-03-22

US20120070425A1

Human necessities

TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC Beta-CELL DYSFUNCTION AND FOR Beta-CELL PROLIFERATION

#8 | 2010-01-14

US20100008899A1

Human necessities

METHODS OF DIAGNOSIS AND TREATMENT FOR METABOLIC DISORDERS

#9 | 2007-10-11

US20070238762A1

Human necessities

Use of Antagonists of Hepatic Sympathetic Nerve Activity

#10 | 2007-01-11

US20070009438A1

Human necessities

Method for diagnosing diabetes type 2 using standardized mixed meal and calculated index values

#11 | 2005-06-09 ✅ Patent 7,622,447 granted on 2009-11-24

US20050124552A1

Human necessities

Use of glutathione synthesis stimulating compounds in reducing insulin resistance

#12 | 2005-06-02

US20050119272A1

Human necessities

Use of phosphodiesterase antagonists to treat insulin resistance

Also check out DiaMedica, Inc.'s (Winnipeg, Canada) applicant profile with 3 patent applications submitted.

AssigneeID:

51933 ⎘